AMPATH plans expansion

IMT News Desk
IMT News Desk
· 2 min read
dna molecular testing

Looks for franchise partners in Hyderabad

American Institute of Pathology & Laboratory Sciences (AMPATH) is looking for franchise partners in Hyderabad as part of expanding its footprint. With its world-class infrastructure and advanced technology, AMPATH has the capabilities to conduct a broad spectrum of tests both routine and super-specialized. They offer affordable diagnostic tests in clinical biochemistry, haematology, clinical pathology, microbiology, immuno phenotyping, serology, cytogenetics and immunology among others.

Currently, AMPATH has 10 existing Labs and 1700+ clients with approximately 2450 tests and profiles conducted. Launched in early 2013, AMPATH represents a new paradigm for pathology services in India as the only reference lab in the country featuring a comprehensive clinical collaboration with an American hospital. Leading clinicians from UPMC’s Pathology Department work hand-in-hand with local AMPATH pathologists to ensure accuracy, quality and on-time reporting with 100% reliable performance.

Commenting on the expansion plans, Ayub Mohammad, COO, AMPATH said, “We are extremely delighted and proud to expand our presence further in India. To make quality diagnostics reach the unpenetrated markets, AMPATH is looking for franchise partners and will extend support with operational excellence and customer service. Our team will work with the franchisee customers to put agreements in place and provide accurate and quality diagnostic services.”

AMPATH Labs have a presence in Telangana, Andhra Pradesh, Karnataka, Tamil Nadu, Kerala, Maharashtra, Uttar Pradesh, Bihar, Jharkhand, West Bengal, North East, Punjab, Delhi NCR, Madhya Pradesh, Chattisgarh, Jammu & Kashmir, Himachal Pradesh, Uttarakhand and reference labs in Nallagandla, Serilingampally, Hyderabad, and Telangana. AMPATH has obtained local accreditation from the National Accreditation Board of Testing and Calibration Laboratories (NABL) and will seek international accreditation from the College of American Pathologists (CAP) in the future. AMPATH also is constantly increasing its already wide-ranging test menu to accommodate the needs of India’s dynamic healthcare landscape.

Read Next

Alembic Pharmaceuticals Limited announces USFDA Tentative Approval for Larotrectinib Capsules
News
June 11, 2026

Alembic Pharmaceuticals Limited announces USFDA Tentative Approval for Larotrectinib Capsules

Alembic Pharmaceuticals Limited (Alembic) announced that it has received tentative approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Larotrectinib Capsules, 25 mg and 100 mg. The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Vitrakvi Capsules, 25 mg and 100 mg, of […]
Article by: IMT News Desk
DFE Pharma earns third consecutive EcoVadis Gold Medal for sustainability performance 
News
June 11, 2026

DFE Pharma earns third consecutive EcoVadis Gold Medal for sustainability performance 

DFE Pharma has earned its third consecutive Gold Medal from EcoVadis, the world leader in corporate sustainability assessments, in recognition of its strong performance in the four themes rated: Environment, Labor & Human Rights, Ethics and Sustainable Procurement. This distinction places DFE Pharma in the top 5% of companies, reflecting the company’s focused efforts to […]
Article by: IMT News Desk
Oval Fertility Inks MoU with Merck to Advance Reproductive Care Standards in India
News
June 11, 2026

Oval Fertility Inks MoU with Merck to Advance Reproductive Care Standards in India

Oval Advanced Fertility Care and Merck Specialities Private Limited, the Indian healthcare arm of Merck KGaA, Darmstadt, Germany and a global leader in fertility sciences with decades of scientific leadership in reproductive medicine, have signed a strategic Memorandum of Understanding (MOU).   India’s IVF market, valued at approximately USD 2.35 billion in 2024, is projected […]
Article by: IMT News Desk
Infosys-backed 4baseCare raises ₹128 crore, plans to take its cancer testing platform global
News
June 11, 2026

Infosys-backed 4baseCare raises ₹128 crore, plans to take its cancer testing platform global

Bengaluru-based precision oncology startup 4baseCare has raised ₹128 crore in its ongoing Series B funding round to expand its hospital-linked genomics laboratory network globally and scale its AI-powered precision oncology platform, OncoTwin. The latest funding round, which follows a first close of ₹90 crore co-led by Ashish Kacholia and Lashit Sanghvi with participation from existing […]
Article by: IMT News Desk